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Mechanical ventilation (MV) is a life-saving intervention for many critically ill patients. Unfortunately, prolonged MV results in rapid diaphragmatic atrophy and contractile dysfunction, collectively termed ventilatorinduced diaphragm dysfunction (VIDD). Recent evidence reveals that endurance exercise training, performed
prior to MV, protects the diaphragm against VIDD. While the mechanism(s) responsible for this exercise-induced
protection against VIDD remain unknown, increased diaphragm antioxidant expression may be required. To
investigate the role that increased antioxidants play in this protection, we tested the hypothesis that elevated
levels of the mitochondrial antioxidant enzyme superoxide dismutase 2 (SOD2) is required to achieve exerciseinduced protection against VIDD. Cause and effect was investigated in two ways. First, we prevented the exercise-induced increase in diaphragmatic SOD2 via delivery of an antisense oligonucleotide targeted against
SOD2 post-exercise. Second, using transgene overexpression of SOD2, we determined the effects of increased
SOD2 in the diaphragm independent of exercise training. Results from these experiments revealed that prevention of the exercise-induced increases in diaphragmatic SOD2 results in a loss of exercise-mediated protection
against MV-induced diaphragm atrophy and a partial loss of protection against MV-induced diaphragmatic
contractile dysfunction. In contrast, transgenic overexpression of SOD2 in the diaphragm, independent of exercise, did not protect against MV-induced diaphragmatic atrophy and provided only partial protection against
MV-induced diaphragmatic contractile dysfunction. Collectively, these results demonstrate that increased diaphragmatic levels of SOD2 are essential to achieve the full benefit of exercise-induced protection against VIDD.

1. Introduction
Mechanical ventilation (MV) is a life-saving intervention for patients in respiratory failure [30]. Conditions that commonly require
ventilator support include critical illnesses, drug overdose, and surgery
[30]. Unfortunately, an unintended consequence of prolonged MV is
the rapid development of diaphragmatic atrophy and contractile dysfunction which is collectively termed ventilator-induced diaphragm
dysfunction (VIDD) [3,16,30,31]. VIDD is predicted to be a major
contributor to difficulties in weaning patients from the ventilator
[7,30]. Indeed, as many as one third of MV patients that are exposed to
⁎

≥ 48 h of ventilator support experience difficult weaning [5,6,30].
Failure to wean from MV is a significant clinical problem as increased
time in the intensive care unit greatly increases the risk of morbidity
and mortality. Currently, no standard clinical therapy exists to prevent
VIDD and therefore, it is imperative to identify biological targets in the
diaphragm that can be manipulated to prevent VIDD.
Endurance exercise training results in a diaphragmatic phenotype
that is protected against VIDD [34]. Although exercise training is not a
practical therapy to prevent VIDD in critically ill patients, identifying
the mechanism(s) responsible for exercise-induced protection of the
diaphragm provides a unique experimental tool in the search for
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molecular targets to prevent VIDD. In this regard, we discovered that
exercise training increases the abundance of a key mitochondrial antioxidant enzyme, superoxide dismutase 2, also known as manganese
superoxide dismutase (SOD2) [34]. This is important because we have
demonstrated that MV-induced oxidative damage to diaphragmatic
mitochondria is essential for the development of VIDD [26]. Indeed,
increases in mitochondrial production of reactive oxygen species (ROS)
drive diaphragmatic atrophy by promoting both a decrease in diaphragmatic protein synthesis and an increase in protein degradation
[28].
SOD2 is located within the mitochondrial matrix and is responsible
for the dismutation of superoxide into hydrogen peroxide. It is encoded
in the nuclear genome and is transported into the mitochondrial matrix
via the mitochondrial “translocase of the outer membrane” and
“translocase of the inner membrane 23″ [8]. Importantly, exercise increases the abundance of SOD2 in both the diaphragm and heart
[14,34,36]. Formally, in studies investigating ischemia reperfusion injury in the heart, we uncovered that SOD2 played a primary role in
exercise-induced cardioprotection [14] and similarly, we predict that
increased SOD2 in the diaphragm may also contribute to exercise-induced protection against VIDD. Therefore, these experiments tested two
hypotheses: 1) endurance exercise-induced protection against VIDD
occurs, in part, due to increases in SOD2 in the diaphragm; and 2)
overexpression of SOD2 in the diaphragm, independent of exercise,
provides protection against VIDD. Using a well-established pre-clinical
model of MV, we determined cause and effect by using innovative
molecular tools to prevent exercise-induced increases in diaphragmatic
SOD2. Further, in separate experiments using viral gene transfection,
we promoted overexpression of SOD2 in the diaphragm, independent of
exercise.

2.3.1. Experiment 1a: Antisense prevention of exercise-induced increases in
SOD2
Experiment 1a determined if preventing the exercise-induced increase in SOD2 using an antisense oligonucleotide against SOD2 results
in diaphragmatic atrophy and contractile dysfunction. Adult female SD
rats were randomly assigned to one of the following experimental
groups (n = 10/group): 1) exercise trained animals with no experimental treatment (Ex) or 2) exercise trained animals injected with antisense oligonucleotide against SOD2 following each exercise session
(Ex-AS). Animals underwent 10 days of endurance exercise training
prior to sacrifice as described below [34]. Twenty-four hours after the
last training session animals were acutely anesthetized and diaphragms
were rapidly removed. Primary dependent variables measured in diaphragm muscle include contractile performance, fiber cross-sectional
area (CSA), SOD2 protein abundance, and SOD2 activity.
2.3.2. Experiment 1b: SOD2 and exercise
To test the hypothesis that the exercise-induced increase in SOD2 is
required for the exercise-induced protection against VIDD, adult female
SD rats were randomly assigned to one of the following experimental
groups (n = 10/group): 1) sedentary controls (CON), 2) sedentary animals exposed to 12 h of MV (MV), 3) exercise trained animals exposed
to 12 hours of MV (MVEx), 4) exercise trained animals injected with
antisense oligonucleotide against SOD2 following each exercise session
and exposed to 12 h of MV (MVEx-AS).
2.3.3. Experiment 2: AAV9 overexpression of SOD2
These experiments tested the prediction that transgenic overexpression of SOD2 alone is sufficient to protect against VIDD. To test
this hypothesis, adult female SD rats were randomly assigned to one of
the following experimental groups (n = 10/group): 1) animals exposed
to sham surgeries with no experimental intervention (CON), 2) animals
exposed to sham surgery and 12 h of MV (MV), 3) animals exposed to
surgical transduction of AAV9 to overexpress SOD2 in the diaphragm
(without MV) (SOD2OvExp) or 4) animals exposed to surgical transduction of AAV9 to overexpress SOD2 in the diaphragm and 12 h of MV
(MV-SOD2OvExp). Note, to avoid republication of data, CON and MV
animals for experiment 2 are different animals from CON and MV animals in experiment 1b.

2. Methods
2.1. Animal model justification
To test our experimental hypothesis, we used a well-established
animal model of MV (i.e., adult female Sprague-Dawley (SD) rats). We
selected the SD rat as the experimental model because the diaphragm of
the SD rat and humans are anatomically similar and share similar
muscle fiber type characteristics [30]. Moreover, female rats were selected because effects of prolonged MV on diaphragm fibers are identical in male and female rats [29,38] and female body weights remain
relatively stable from 3 to 8 months of age [24]. Animals were 3–5
months of age and ~ 250 g at the time of our experiments.

2.4. General methods
2.4.1. Mechanical ventilation
Aseptic techniques were adopted for all surgical procedures. Prior to
initiation of MV, animals were injected with an IP injection of sodium
pentobarbital (60 mg/kg body weight). Upon reaching a stage 3 plane
of anesthesia (i.e, surgical plane of anesthesia), animals underwent a
tracheostomy and were mechanically ventilated with a pressure-controlled ventilator (Servo Ventilator 300; Siemens, Munich, Germany)
utilizing the “controlled MV” mode. In this mode, the ventilator performs the full work of breathing and the animal cannot trigger the
ventilator. Animals were ventilated for 12 h at the following ventilator
settings: upper airway pressure limit: 20 cmH2O; respiratory rate:
80 bpm; positive end-expiratory pressure: 1 cmH2O.
Post tracheostomy, both the carotid artery and jugular vein were
cannulated for measurement of arterial blood pressure and continuous
infusion of anesthesia (sodium pentobarbital, ~ 10 mg kg−1 h−1) respectively. In addition, arterial blood samples were obtained periodically to monitor arterial blood gas values (i.e., PaCO2 PaO2, and pH)
(GEM Premier3000; Instrumentation Laboratory, Lexington, MA).
When necessary, adjustments to both alveolar ventilation and inspired
fractions of oxygen were performed to maintain blood gas and pH
homeostasis during the 12 h of MV. Importantly, we have previously
shown that in spontaneously breathing animals, anesthesia treatment
does not adversely affect either diaphragm fiber CSA or contractile

2.2. Animal housing and diet
All animals were housed at the University of Florida Animal Care
Services Center according to guidelines set forth by the Institutional
Animal Care and Use Committee. Additionally, the University of Florida
Animal Care and Use Committee approved these experiments. The experimental animals were maintained on a 12:12 h light-dark cycle and
provided food and water ad libitum throughout the experimental
period.
2.3. Experimental design
These experiments tested two hypotheses: 1) endurance exerciseinduced protection against VIDD occurs, in part, due to increases in
SOD2 in the diaphragm; and 2) overexpression of SOD2 in the diaphragm, independent of exercise, provides protection against VIDD.
First, we determined if prevention of the exercise-induced increase in
SOD2 in the diaphragm will avert the exercise-induced protection of
VIDD (Experiments 1a and 1b). Second, we tested the hypothesis that
transgenic overexpression of SOD2 in the diaphragm is sufficient to
protect against VIDD (Experiment 2). A brief description of the experimental designs and general methods for these experiments follows.
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function [29].
During prolonged MV, continuous care was provided to the animals
in the form of eye lubrication, expressing the bladder, removing airway
mucus, and rotating the animals to combat blood pooling. A recirculating warming blanket was used to maintain body temperature at
~ 37 °C and heart rate was measured by lead II of an electrocardiograph. Finally, animals received glycopyrrolate (0.04–0.08 mg/
kg) intramuscularly every 2 h throughout MV to reduce airway secretions. Following 12 h of MV, the diaphragm was rapidly removed for
subsequent analysis.

collection of the supernatant, protein content was assessed via Bradford
method (Sigma-Aldrich) [37]. A rat SOD2 enzyme-linked immunosorbent assay kit (ELISA) (Life Span BioSciences, Inc.; LS-F6964)
was used to determine total protein abundance of SOD2 in the diaphragm [23].
2.5.2. SOD2 enzyme activity
SOD2 activity in the diaphragm was measured with a commercially
available enzyme activity kit according to the manufacturer's instructions (Cayman Chemical, Ann Arbor, MI Superoxide Dismutase Assay
Kit; 706002), with the addition of 2 mM KCN to inhibit copper and zinc
SOD. Briefly, tissue samples were homogenized 1:10 (mg wt/μL buffer)
in 20 mM Hepes, 1 mM EGTA, 210 mM mannitol, and 70 mM sucrose
(pH 7.2) and centrifuged at 1500 g for 5 min at 4 °C. SOD2 activity was
normalized to protein concentration in the homogenate.

2.4.2. Survival surgery for AAV9-SOD2 administration
Four weeks prior to MV, animals were injected with AAV9-SOD2
directly into the diaphragm. This time point was selected based on
preliminary experiments indicating that four weeks following transfection is sufficient time to result in a stable expression of the transfected gene; complete details of our diaphragm gene transfection protocol can be found elsewhere [33,35]. Briefly, animals were initially
anesthetized using 2–4% inhaled isoflurane followed by continuous
anesthesia (with 0.5–2.5% inhaled isoflurane) administered via nosecone throughout the surgical procedure. Excess isoflurane was scavenged with two Omnicon f/air canisters. All surgical procedures were
performed under aseptic conditions by an experienced rodent surgeon.
After reaching a surgical plane of anesthesia, a midline incision was
made through the skin extending from the xiphoid process to the suprapubic region, the liver was retracted, and the diaphragm was injected as described previously [33]. Prior to awakening from the anesthetic, the animals received 6–8 mL subcutaneous fluids (0.9%
Sodium Chloride) that had been warmed to 37 °C and Buprenorphine
(0.05–0.1 mg/kg) for post-surgical relief of pain.

2.5.3. Glutathione reductase activity
Diaphragmatic glutathione reductase activity was measured with an
enzyme activity kit (Cayman Chemical, Glutathione Reductase Assay
Kit; 703202). Briefly, tissue samples were homogenized 1:10 (mg wt/μL
buffer) in 20 mM Hepes, 1 mM EGTA, 210 mM mannitol, and 70 mM
sucrose (pH 7.2) and centrifuged at 1500g for 5 min at 4 °C. After
measuring the total glutathione reductase activity, the activities were
normalized by the protein concentrations.
2.5.4. Measurement of protein carbonyls
Protein carbonylation in diaphragm samples was measured by a
commercially available OxyBlot kit (Millipore, S7150) in the soluble
fraction for experiment 1b while measured in the insoluble fraction in
experiment 2.

2.4.3. Exercise training protocol
Animals in the exercise group performed 5 consecutive days (d) of
progressive habituation to treadmill running. Following 2 d of rest, each
animal performed 10 d of treadmill running for 60 min/day at 30 m/
min, 0% grade (estimated work rate of 70% VO2 max) with 2 d rest after
day 5 of training. We chose this protocol based on previous experiments
demonstrating its ability to promote exercise-induced protection of the
diaphragm from VIDD [34]. Animals were ventilated ~ 24 h following
the final exercise bout.

2.5.5. Real-time polymerase chain reaction (PCR)
Total RNA was isolated from ~ 25 mg of diaphragm muscle tissue
using Trizol reagent (Life Technologies, Carlsbad, CA). RNA was reverse
transcribed using Superscript VILO (Invitrogen). PCR was performed as
described previously [35]. mRNA transcripts were assayed using commercially available rat primer and probe sequences from Applied Biosystems: Fbxo32 for atrogin-1/MAFbx (Rn00591730_m1), Trim63 for
MuRF1 (Rn00590197_m1), GUSB for β-glucronidase (Rn00566655_m1)
was used as a reference gene.

2.4.4. Preventing the exercise-induced increase of SOD2
Immediately following each 60 min exercise bout, animals received
an IP injection with an antisense oligonucleotide phosphorothioate (
5′-CACGCCGCCCGACACAACATTG-3′) at a dose of (10 mg/kg) targeted
against SOD2 to inhibit protein translation. Previous reports have
confirmed the effectiveness of this dosing protocol to prevent exerciseinduced increases in SOD2 in skeletal muscle and heart [14].

2.5.6. Western blot analysis
Western blots were conducted on diaphragm protein as described
previously with minor modifications [19]. Briefly, supernatant was
drawn off and protein was assessed via Bradford method (Sigma), followed by normalizing the protein concentrations in Laemmli sample
buffer (1610747, Bio Rad Hercules, CA) containing 5% dithiothreitol.
Proteins were loaded on 4–20% gradient Criterion TGX gels (Bio-Rad)
and transferred to LF-PVDF membrane (Millipore Burlington, MA).
Following transfer, membranes were blocked in 5% milk solution for
2 h at room temperature; followed by incubation with primary antibodies. Membranes were exposed to either Alexa Fluor 680 IgG or 800
IgG (Odyssey Li-Cor) secondary for 30 min at 25 °C. Membranes were
scanned and analyzed with the Li-Cor Odyssey Infrared Imager (Li-Cor
Biosciences) using Odyssey 2.1 software. Primary antibodies of interest
were superoxide dismutase 1 (SOD1) (Santa Cruz, sc-11407, 1:1000
incubated overnight at 4 °C secondary concentration 1:20,000), Glutathione peroxidase (Gpx1), (Santa Cruz, sc22145, 1:200 incubated
1.5 h at 25 °C secondary concentration 1:5000), Catalase (Gene Tex,
GTX110704, 1:1000 incubated overnight at 4 °C secondary concentration 1:20,000), αII-spectrin (Santa Cruz, sc48382, 1:250 incubated
overnight at 4 °C then 3 h at 25 °C secondary concentration 1:5000),
calpastatin (Santa Cruz, sc20779, 1:500 incubated 3 days at 4 °C secondary concentration 1:5000), LC3 II (Cell Signaling, 2775, 1:500 incubated overnight at 4 °C secondary concentration 1:5000), and citrate
synthase (Abcam, ab66600, 1:1000 incubated overnight at 4 °C

2.4.5. AAV9 overexpression of SOD2
AAV9-CMV-SOD2 (AAV-290654) was purchased from Vector
Biolabs (Malvern, PA). Four weeks prior to MV, animals designated to
overexpress SOD2 underwent abdominal surgery for eight evenly
spaced direct diaphragm injections of AAV9 at a concentration of
1 × 1011 viral genomes as previously described [33]. The dose of
1 × 1011 viral genomes was selected based on our prior experience with
diaphragm protein overexpression utilizing an AAV9 serotype with
CMV promotor driven expression; importantly, this approach results in
overexpression of the transgene in ~ 80% of diaphragm fibers (independent of fiber type) [33].
2.5. Biochemical measurements
2.5.1. SOD2 protein abundance
Diaphragm samples were homogenized 1:10 (mg wt/μL buffer) in
5 mM Tris (pH 7.5) and centrifuged at 1500g for 5 min at 4 °C. Upon
404
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secondary concentration 1:20,000). All westerns were normalized using
the total protein in each lane labeled with Revert protein stain (Li-Cor),
like Coomassie Blue. The 40 kDa band for total protein is shown as a
representative image of the protein loading as reported previously [2].

Amplex™ UltraRed (Molecular Probes, Eugene, OR) (10 μM)/horseradish peroxidase (1 U/mL) system. The assay was performed at 37 °C
in a magnetic stirring cuvette using succinate as the substrate.
Specifically, this assay uses horseradish peroxidase to catalyze the
H2O2-dependent oxidation of non-fluorescent Amplex™ UltraRed to a
fluorescent resorufin, and it was used to measure H2O2 as an indicator
of superoxide production. Excitation and emission was set at 565 and
600 respectively. Blebbistatin (25 μM) prevented myofiber contraction
during the measurements. The levels of resorufin were recorded every
30 s for 10 min, and H2O2 production was calculated using a standard
curve. Each fiber bundle was washed and dehydrated for normalization
of the measurements. The rate of ROS production was expressed as
H2O2 emission in pmol·min−1 mg−1 dry wt.

2.6. Histological measurements
2.6.1. Diaphragm myofiber CSA
Frozen diaphragm sections were cut at a thickness of 10 µm with a
cryostat (HM 550 Cryostat, Thermo Scientific, Waltham, MA) and
stained for dystrophin (Thermo Scientific #RB-9024-R7), myosin heavy
chain I (Hybridoma Bank A4.840 s IgM 1:15), and myosin heavy chain
IIa (Hybridoma Bank SC-71c IgG 1:50) for CSA analysis. CSA was
analyzed with Scion Image software (National Institutes of Health) as
previously described [19].

2.8. Statistical analysis
Group sample size was determined via a power analysis using preliminary data from our laboratory. Comparisons between groups were
made by a one-way ANOVA, and when appropriate a Tukey HSD test
was performed post hoc. Significance was established at p < 0.05.

2.7. Functional measurements
2.7.1. Diaphragmatic contractile function
To assess diaphragm contractile function, a costal diaphragm
muscle strip (~ 3 mm wide), including the tendinous attachments at the
central tendon and rib cage was suspended vertically between two
lightweight Plexiglas clamps with one end connected to an isometric
force transducer (model FT-03, Grass Instruments, Quincy, MA) within
a jacketed tissue bath containing 25 °C Krebs-Hensleit solution equilibrated with 95% O2–5% CO2 gas. Optimal muscle length (L0) was found
and then the muscle was electrically stimulated using field stimulation
to contract over a frequency range of 15–160Hz. The force output was
recorded using LabView (National Instruments Corporation, Austin, TX)
as previously described [27,55]. To control for differences in muscle
strip size, force production was normalized to physiological CSA and
specific force production was compared between the experimental
groups.

3. Results
Animals used in these experiments were 3–5 months of age with no
significant differences in body weight between groups (n = 10/group):
Experiment 1a (Ex = 257 g ± 10.4, Ex-AS = 249 g ± 11.1). The following is a summary of our experimental findings.
3.1. Experiment 1a
3.1.1. Physiological response to SOD2 antisense oligonucleotide treatment
To determine if administration of an antisense oligonucleotide directed against SOD2 resulted in alterations in diaphragm muscle fiber
CSA and contractile function, animals were trained for 10 days and
administered either saline or antisense following each training session.
Our results demonstrate that compared to Ex animals, antisense treatment is sufficient to prevent the exercise-induced increase in SOD2
levels but did not impact diaphragm fiber CSA and specific force production (Fig. 1C-D).

2.7.2. Permeabilized muscle fiber preparation
Approximately 15 mg of costal diaphragm muscle was dissected and
placed on a plastic Petri dish filled with ice-cold buffer X (60 mM KMes, 35 mM KCl, 7.23 mM K2EGTA, 2.77 mM CaK2EGTA, 20 mM imidazole, 0.5 mM dithiothreitol, 20 mM taurine, 5.7 mM ATP, 15 mM PCr,
and 6.56 mM MgCl2, pH 7.1). The muscle was then cut into four ~ 3 mg
pieces and gently separated to expose each fiber in ice-cold buffer X.
Muscle fiber bundles were then placed on a rotator for 30 min at 4 °C in
ice-cold buffer X containing 75 μg mL−1 saponin. Finally, the permeabilized fiber bundles were washed three times for 5 min in ice-cold
buffer Z (110 mM K-Mes, 35 mM KCl, 1 mM EGTA, 5 mM K2HPO4, and
3 mM MgCl2, 0.005 mM glutamate, 0.02 mM malate, and 0.5 mg · mL−1
BSA, pH 7.1).

3.2. Experiment 1b
3.2.1. Biological responses to mechanical ventilation
Importantly, no significant differences existed in heart rates, blood
gases, and blood pressure between the experimental groups at the
conclusion of the experimental protocols (Table 1). Even though we
have demonstrated previously that VIDD is not caused by barotrauma
[6], we visually examined the lungs for signs of damage and the peritoneal cavity for evidence of infection. Our examination revealed no
visual evidence of barotrauma in the lungs and no evidence of infection
existed following the 12-h MV protocol.

2.7.3. Diaphragm mitochondrial respiration in permeabilized fibers
Mitochondrial respiration was measured polarographically in a respiration chamber (Hansatech Instruments) maintained at 37 °C. After
the respiration chamber was calibrated, permeabilized fiber bundles
(~ 3 mg) were incubated with 1 mL of respiration buffer Z containing
20 mM creatine to saturate creatine kinases [56,57]. Flux through
complex I was measured using 5 mM pyruvate and 2 mM malate. The
ADP-stimulated respiration (state 3) was initiated by adding 0.25 mM
ADP to the respiration chamber. Basal respiration (state 4) was determined in the presence of 10 μg/mL oligomycin to inhibit ATP
synthesis. The respiratory control ratio (RCR) was calculated by dividing oxygen consumption during state 3 respiration by the oxygen
consumption during state 4 respiration.

3.2.2. Antisense treatment prevents the exercise-induced increase of SOD2
protein abundance and activity in the diaphragm of mechanically ventilated
animals
Post-exercise treatment with an antisense oligonucleotide directed
against SOD2 prevented the exercise-induced increase in protein
abundance of SOD2 in the diaphragm of mechanically ventilated animals (Fig. 2 A). Importantly, antisense treatment did not reduce SOD2
levels in the diaphragm below control levels.
3.2.3. Elevated SOD2 contributes to exercise-induced protection against
MV-induced contractile dysfunction in the diaphragm
To determine if increased SOD2 in the diaphragm is essential for
exercise-induced protection against MV-induced diaphragm contractile
dysfunction, we measured contractile properties in strips of costal
diaphragm muscle in vitro. Consistent with previous studies

2.7.4. Diaphragm mitochondrial ROS production in permeabilized fibers
Mitochondrial H2O2 emission rate was measured continuously in
permeabilized fiber bundles (~ 3 mg) via a spectrofluorometer
(Fluorolog-3 HORIBA Jobin Yvon, Edison, NJ, USA) at 37 °C with
405
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Fig. 1. Antisense oligonucleotide prevents the exercise-induced increase in
SOD2 activity and protein abundance
without altering CSA and diaphragm
muscle force. A) ELISA of diaphragm
SOD2 protein abundance, n = 10, B)
SOD2 activity, n = 8, C) diaphragm
CSA, n = 10, and D) force frequency
curve, n = 10. Values are mean percent
change of control ± SE. CON, control
(dotted line is representative control
value); Ex, exercise; Ex-AS, exercise
with antisense. * p < 0.05 Ex is different from Ex-AS.

Table 1
At the conclusion of the experimental protocols in experiment 1B, no significant
differences existed between experimental groups in body weight, heart rate
(HR), arterial partial pressure of carbon dioxide (PaCO2), arterial pressure of
oxygen (PaO2), arterial pH, and systolic blood pressure (SBP). Data presented as
mean ± standard deviation.

Weight (g)
HR
PaCO2 (mmHg)
PaO2 (mmHg)
pH
SBP (mmHg)

MV

MVEx

MVEx-AS

250 ± 15
354 ± 30
37 ± 7.7
70 ± 11
7.46 ± 0.05
122 ± 16

260 ± 15
351 ± 20
33 ± 3.8
73 ± 8
7.47 ± 0.03
117 ± 10

260 ± 17
337 ± 18
34 ± 6.8
76 ± 16
7.50 ± 0.05
110 ± 10

[1,3,10,15,17], prolonged MV resulted in a significant decrease in the
diaphragm force-frequency curve. Importantly, animals exposed to
endurance exercise training prior to MV were protected against this
MV-induced diaphragmatic contractile dysfunction. However, when the
exercise-induced increase in SOD2 in the diaphragm was prevented,
exercise-induced protection against MV-induced diaphragmatic dysfunction was partially attenuated (Fig. 2C).
3.2.4. Increased expression of SOD2 in the diaphragm contributes to
exercise training-induced protection against MV-induced diaphragmatic
atrophy
Similar to previous findings, exercise training preconditioned the
diaphragm and protected against MV-induced fiber atrophy [34]. Importantly, treatment of animals with the antisense oligonucleotide
against SOD2 abolished the exercise-induced protection against MVinduced atrophy in all diaphragm fiber types (Fig. 2D).

assessed by RCR. Prolonged MV resulted in mitochondrial uncoupling
as evidenced by a significantly lower RCR; however, exercise training
performed prior to MV resulted in protection against MV-induced mitochondrial uncoupling (Fig. 3A). Moreover, prevention of the exerciseinduced increase in SOD2 in diaphragm mitochondria did not decrease
this exercise-induced protection against MV-induced mitochondrial
uncoupling.
We next measured citrate synthase protein content in diaphragm
fibers as a surrogate biomarker of mitochondrial volume. Importantly,
treatment of animals with the antisense oligonucleotide against SOD2
did not decrease citrate synthase activity in the diaphragm (Fig. 3C).
3.2.6. Exercise training protects against MV-induced increases in
mitochondrial ROS emission
Consistent with previous findings, prolonged MV resulted in a significant increase in diaphragmatic mitochondrial ROS emission and 10
days of exercise training prevented the increased ROS in the diaphragm
[34]. Interestingly, preventing the exercise-induced increase in SOD2
did not result in increased H2O2 production from the mitochondria
(Fig. 3B). Protein carbonyls in the diaphragm were measured as a
biomarker of oxidative stress; paradoxically, despite an increase in ROS
emission from mitochondria during MV, no differences existed between
experimental groups in diaphragm levels of protein carbonylation
(Fig. 3D).
3.2.7. Reduced SOD2 in exercise-trained diaphragms results in increased
glutathione reductase activity during MV
Glutathione reductase is an antioxidant enzyme that maintains the
pool of reduced glutathione by recycling glutathione disulfide back to
its reduced form [9]. In studies where SOD2 is in a lower abundance in
cells, reduced glutathione is also lower suggesting that there is a
compensatory interplay between SOD2 and glutathione [4]. Therefore,
we measured the activity of glutathione reductase in the diaphragm of
all experimental groups. Compared to both groups of exercise trained
animals exposed to MV, glutathione reductase activity was significantly
lower in the diaphragm of sedentary animals exposed to prolonged MV.
Surprisingly, preventing the exercise-induced increase in SOD2 resulted

3.2.5. Increased SOD2 is not required to rescue mitochondria from MVinduced uncoupling
To determine if the exercise-induced increase in SOD2 in the diaphragm is required for protection against MV-induced mitochondrial
dysfunction in diaphragm fibers, mitochondrial respiration was measured during both state 3 and state 4, mitochondrial coupling was
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Fig. 2. Treatment of animals with an antisense oligonucleotide against SOD2 prevents the exercise-induced increase in SOD2 activity and protein abundance in the
diaphragm while attenuating exercise protection against VIDD and abolishing exercise protection against atrophy. A) ELISA of SOD2 protein abundance in diaphragm, n = 9/group. B) SOD2 activity in diaphragm, n = 8/group. Values are mean percent change of control ± SE. # p < 0.05 different from MVEx; δ p < 0.05
different from all groups. C) Diaphragm specific force, n = 10/group. Values are mean ± SE. * p < 0.05 MV different from CON, # p < 0.05 MV different from
MVEx; θ p < 0.05 MVEx-AS different from CON; δ p < 0.05 MV different from all groups. D) Diaphragm cross-sectional area. Values are mean ± SE. * p < 0.05
different from CON, # p < 0.05 different from MVEx.

Fig. 3. Impact of MV on mitochondrial contents, respiration, hydrogen peroxide emission, glutathione reductase, and protein carbonyls in diaphragm. A) Respiratory
control ratio (RCR) calculated by mitochondrial state 3 respiration/state 4 respiration, n = 9/group. B) Mitochondrial hydrogen peroxide emission n = 10/group.
Values are mean ± SE. # p < 0.05 different from MVEx, δ p < 0.05 different from all groups. C) Diaphragm citrate synthase levels in diaphragm muscle used as a
marker of mitochondrial volume, n = 8/group. D) Protein carbonyls, n = 10/group. E) Glutathione Reductase activity determined colorimetrically by measuring the
rate of NADPH oxidation in diaphragm samples n = 7/group. Values are mean percent change of control ± SE. * p < 0.05 different from CON, # p < 0.05 different
from MVEx, δ p < 0.05 different from all groups.
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Fig. 4. Diaphragm antioxidant enzymes after 12 h of MV. A) representative protein blots, B) superoxide dismutase 1 (SOD1), C) glutathione peroxidase 1 (Gpx1), D)
Catalase (CAT). n = 8/group for all graphs. Values are mean percent change of control ± SE.

3.3. Experiment 2

in elevated glutathione reductase activity in the diaphragm following
MV compared to all other groups (Fig. 3E).

3.3.1. Biological responses to mechanical ventilation
No significant differences existed in heart rates, blood gases, and
blood pressure between the experimental groups at the conclusion of
the experimental protocols (Table 2). Even though we have demonstrated previously that VIDD is not caused by barotrauma [6], we visually examined the lungs for signs of damage and the peritoneal cavity
for evidence of infection. Our examination revealed no visual evidence
of barotrauma in the lungs and no evidence of infection existed following the 12-h MV protocol.

3.2.8. Exercise training and diaphragm antioxidant enzymes
A complex network of antioxidant enzymes exist in skeletal muscle
fibers [27]. To determine if exercise training increases the abundance of
key antioxidant enzymes in the diaphragm, we measured the protein
abundance of SOD1, Gpx1, and CAT. Although exercise training significantly increased diaphragmatic levels of SOD2 in mechanically
ventilated animals (Fig. 2A), exercise did not alter diaphragmatic levels
of SOD1, Gpx1 and CAT (Fig. 4A-D). Additionally, prevention of exercise-induced increases in diaphragmatic SOD2 did not impact diaphragmatic levels of any of these antioxidant enzymes (Fig. 4A-D).

3.3.2. AAV9-mediated overexpression of SOD2 protein abundance and
activity in the diaphragm
Four weeks prior to MV, diaphragms underwent viral transduction
with an AAV9 to overexpress SOD2. Fig. 6 demonstrates that diaphragm
transduction with AAV9-SOD2 increased SOD2 protein abundance
compared to control and mechanically ventilated sham treated animals
(Fig. 6A). In addition, SOD2 activity was significantly increased in
control animals overexpressing SOD2 compared to MV animals
(Fig. 6B).

3.2.9. Exercise training protects against MV-induced proteolysis in the
diaphragm
Prolonged MV results in calpain activation and increased ubiquitination in the diaphragm; importantly, active calpain promotes diaphragmatic atrophy and contractile dysfunction [12,21]. The current
study confirms that endurance exercise training preconditions the diaphragm and protects against MV-induced increases in proteolysis.
Specifically, compared to both CON and MVEx animals, ubiquitin ligase
mRNA expression (MuRF1 and Atrogin-1) was increased in the diaphragms of both MV and MVEx-AS (Figs. 5C and 5D). Calpain activation in the diaphragm was measured by the accumulation of the calpain-specific cleavage product of αII-spectrin and calpain activity in the
diaphragm was higher in both MV and MVEx-AS animals compared to
MVEx and CON (Fig. 5B). As reported previously, LC3 II was used as a
marker of autophagosome content [18]. Preventing the exercise induced increase of SOD2 resulted in a significant increase in diaphragmatic levels of LC3 II following prolonged MV (Fig. 5F).

3.3.3. SOD2 overexpression in the diaphragm partially prevents MVinduced contractile dysfunction
To determine if an increase in SOD2 alone is sufficient to protect
against MV-induced diaphragm contractile dysfunction, we measured
diaphragm force-frequency response in vitro from strips of costal diaphragm muscle. Importantly, overexpression of SOD2 in the diaphragm
does not affect contractile function compared to control animals. In
agreement with Experiment 1b, MV resulted in a significant reduction
in diaphragm muscle specific force production. Finally, transgenic
overexpression of SOD2 in the diaphragm partially attenuated the MVinduced decrease in specific force (Fig. 6C).
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Fig. 5. Diaphragm proteolytic pathways are increased in animals lacking the exercise-induced increase in SOD2. A) Diaphragm αII-spectrin degradation was used as
an assessment of calpain activity from experiment 2. Representative image of αII-spectrin and total protein, n = 8/group, B) αII-spectrin protein degradation from
experiment 2, n = 8/group, C) MuRF1 mRNA expression from experiment 2, n = 6/group, D) Atrogin-1 mRNA expression, n = 6/group, E) Diaphragm LC3 II was
used as a marker of autophagosome formation in experiment 2. Representative image of LC3 II and total protein, F) LC3 II protein from experiment 2, n = 8. Values
are mean percent change of control ± SE. * p < 0.05 different from CON, # p < 0.05 different from MVEx, θ p < 0.05 different from MV.

increase in mitochondrial ROS production in diaphragm fibers [26].
Transgenic overexpression of SOD2 in the diaphragm did not alter
mitochondrial ROS emission in either control animals or animals exposed to prolonged MV (Fig. 7B).

Table 2
At the conclusion of the experimental protocols in experiment 2, no significant
differences existed between experimental groups in body weight, heart rate
(HR), arterial partial pressure of carbon dioxide (PaCO2), arterial pressure of
oxygen (PaO2), arterial pH, and systolic blood pressure (SBP). Data presented as
mean ± standard deviation.

Weight (g)
HR
PaCO2 (mmHg)
PaO2 (mmHg)
pH
SBP (mmHg)

CON

MV

SOD2 OvExp

250 ± 20

255 ± 18
255 ± 18
346 ± 22
36 ± 7.9
86 ± 19
7.47 ± 0.09
134 ± 29

3.3.7. Overexpression of SOD2 in the diaphragm does not impact
glutathione reductase activity
Glutathione reductase plays a key role in maintaining adequate levels of reduced glutathione in the cell by converting oxidized glutathione to reduced glutathione. Importantly, overexpression of SOD2
in the diaphragm did not alter glutathione reductase activity in the
diaphragm (Fig. 7E).

MVSOD2 OvExp
258 ± 9
358 ± 28
39 ± 3.8
78 ± 8.4
7.44 ± 0.03
138 ± 20

3.3.4. Overexpression of SOD2 does not protect the diaphragm against MVinduced fiber atrophy
To determine if SOD2 overexpression in the diaphragm is protective
against MV-induced myofiber atrophy, we measured costal diaphragm
myofiber CSA. Although transgenic overexpression of SOD2 alone in
the diaphragm did protect against MV-induced atrophy of type I muscle
fibers, overexpression of SOD2 did not protect against MV-induced
diaphragmatic atrophy in either type IIa or type IIb/x fibers (Fig. 6D).

3.3.8. Overexpression of SOD2 does not impact diaphragmatic abundance
of key antioxidant enzymes
To determine if transgenic overexpression of SOD2 influenced the
abundance of key antioxidant enzymes in the diaphragm, we measured
the protein abundance of three primary antioxidant enzymes. Our results reveal that overexpression of SOD2 in the diaphragm did not
impact diaphragm levels of SOD1, Gpx1, and CAT (Fig. 8A-D).

3.3.5. SOD2 overexpression in the diaphragm provides partial protection
against MV-induced mitochondrial uncoupling
To determine if SOD2 overexpression in the diaphragm is protective
against MV-induced mitochonodrial dysfunction, mitochondrial respiration was measured in conditions of both state 3 and state 4. The
MV-induced decrease in RCR was partially protected in MV animals
overexpressing SOD2 (Fig. 7A).

3.3.9. Overexpression of SOD2 in the diaphragm partially prevents
increased proteolysis
Prolonged MV results in increased ubiquitin ligase mRNA in the
diaphragm; importantly, the current study demonstrates that overexpression of SOD2 in the diaphragm partially protects against MVinduced increases in mRNA expression of the E3 ubiquitin ligases
MuRF1 and Atrogin-1 (Fig. 9C-D). Also, overexpression of SOD2 in the
diaphragm prior to MV did not prevent a rise in LC3 II protein content
in the diaphragm (Fig. 9E-F). Taken collectively, these data suggest that
SOD2 plays a role in MuRF1 and Atrogin-1 mRNA.

3.3.6. Overexpression of SOD2 in the diaphragm does not protect against
MV-induced increases in mitochondrial ROS emission
Consistent with previous findings, prolonged MV results in a marked
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Fig. 6. Protein abundance of successful
SOD2 overexpression in the diaphragm
as well as activity, diaphragm specific
force, and cross-sectional area. A)
ELISA of SOD2 protein abundance,
n = 9/group. B) SOD2 activity, n = 7/
group. Values are mean percent change
of control ± SE. * p < 0.05 different
from CON, # p < 0.05 different from
SOD2OvExp, δ p < 0.05 different
from all groups. C) Diaphragm specific
force n = 10/group. Values are
mean ± SE. * p < 0.05 MV different
from CON, # p < 0.05 MV different
from SOD2OvExp, δ p < 0.05 MV different from all groups. D) Diaphragm
cross-sectional area, n = 10/group.
Values are mean ± SE. * p < 0.05
different from CON, # p < 0.05 different from SOD2OvExp.

4. Discussion

Our findings support the hypothesis that increases in diaphragmatic
SOD2 play a key role in exercise-induced protection against VIDD. In
contrast, transgenic overexpression of SOD2 alone in the diaphragm
provides only partial protection against VIDD. These novel findings
provide new insight on the mechanisms mediating exercise-protection
against VIDD. A critique of our experimental approach and a detailed
discussion of our findings follows.

4.1. Overview of principal findings
The experiments tested two related hypotheses: 1) endurance exercise-induced protection against VIDD occurs, in part, due to increases
in SOD2 in the diaphragm; and 2) overexpression of SOD2 in the diaphragm, independent of exercise, provides protection against VIDD.

Fig. 7. Impact of MV on mitochondrial volume, respiration, hydrogen peroxide emission, glutathione reductase, and protein carbonyls in diaphragm. A) Respiratory
control ratio (RCR) calculated by mitochondrial state 3 respiration/state 4 respiration, n = 9/group. B) Mitochondrial hydrogen peroxide emission, n = 7/group.
Values are mean ± SE. * p < 0.05 different from CON, # p < 0.05 different from SOD2OvExp. C) Diaphragm citrate synthase levels in diaphragm muscle used as a
marker of mitochondrial volume, n = 10/group. D) Protein carbonyls, n = 10/group. E) Glutathione reductase activity determined colorimetrically by measuring the
rate of NADPH oxidation in diaphragm samples, n = 7/group. Values are mean percent change of control ± SE.
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Fig. 8. Impact of MV on diaphragm antioxidant enzymes, probed for on separate membranes. A) Representative images of diaphragm antioxidant proteins. B)
Superoxide dismutase 1 (SOD1). C) Glutathione peroxidase 1 (Gpx1). D) Catalase (CAT). n = 10/group in all graphs. Values are mean percent change of
control ± SE.

4.2. Critique of experimental model

4.3. Exercise-induced increases in SOD2 in the diaphragm are required to
achieve the full benefit of exercise-induced protection against VIDD

Due to the invasive nature of these studies, our experiments were
performed using a preclinical animal model of MV. The rat was selected
as the experimental model because the rat diaphragm shares both
anatomic and muscle fiber type similarities with human diaphragm
[22,25]. Importantly, prolonged MV results in similar rates of diaphragmatic atrophy and contractile dysfunction in rats and humans
[30].
The current experiments investigated mitochondrial function and
ROS in a permeabilized fiber preparation. While this preparation possesses the advantage of studying mitochondrial function within their
normal reticulum formation within muscle fibers, there are also
limitations with this experimental approach. ROS generated from
succinate-induced conditions is a supraphysiological consequence of
electron backflow from high complex II activity with low complex
I activity in the absence of ADP, which does not happen in vivo [20].
However, measurement of hydrogen peroxide in the exogenous buffer
does not reveal whether the primary site of hydrogen peroxide production is the subsarcolemma or intermyofibrillar mitochondria. Further, our permeabilized fiber preparation cannot determine if ROS
measured in the exogenous buffer is exclusively from mitochondria or
other sources (e.g., NADPH oxidase). Nevertheless, previous experiments from our group have demonstrated that the mitochondria are the
major sources of hydrogen peroxide production during MV [26].

Our results provide the first evidence that an exercise-induced increase in SOD2 is an essential link in the chain of exercise-induced
changes in diaphragm fibers that provide protection against MV-induced diaphragm contractile dysfunction, fiber atrophy, and calpain
activation. Hence, these findings support our prediction that SOD2 is a
critical player in the exercise-induced protection against VIDD. This
hypothesis evolved from our previous work revealing that MV-induced
oxidative stress in the diaphragm is essential for the development of
VIDD (reviewed in 30 [30]). More specifically, increased mitochondrial
ROS emission in the diaphragm is a required upstream trigger to promote both accelerated proteolysis and contractile dysfunction in the
diaphragm during prolonged MV [26]. Therefore, we postulated that
exercise-induced increases in mitochondrial antioxidant defenses (i.e.,
SOD2) would lower MV-induced mitochondrial ROS emission and
protect against MV-induced diaphragmatic atrophy and contractile
dysfunction. Our results support this prediction and demonstrate that
increased SOD2 abundance in diaphragm fibers is essential to achieve
the full benefit of exercise-induced protection against MV-induced
contractile dysfunction [34]. Specifically, prevention of the exerciseinduced increase in SOD2 abundance in the diaphragm attenuated exercise-mediated protection against MV-induced diaphragm contractile
dysfunction. We interpret this finding as evidence that while an increase in diaphragmatic SOD2 contributes to exercise-induced
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Fig. 9. Transgenic overexpression of SOD2 in the diaphragm alters proteolytic pathways. A) Diaphragm αII-spectrin degradation was used as an assessment of calpain
activity from experiment 2, Representative image of αII-spectrin and total protein, n = 8/group. B) αII-spectrin protein degradation from experiment 2, n = 8/group.
C) MuRF1 mRNA expression from experiment 2, n = 6/group. D) Atrogin-1 mRNA expression, n = 6/group. E) Diaphragm LC3 II was used as a marker of autophagosome formation in experiment 2. Representative image of LC3 II and total protein. F) LC3 II protein from experiment 2 n = 8/group. Values are mean percent
change of control ± SE. *p < 0.05 different from CON, # p < 0.05 different from SOD2OvExp, δ p < 0.05 different from all groups.

increase in SOD2 abolished the exercise-induced protection against
elevated MuRF1 and Atrogin-1 mRNA expression in diaphragms from
animals exposed to prolonged MV. Together, these results indicate that
increased SOD2 is required for the exercise-induced protection against
MV-induced increases in proteolysis in the diaphragm. A logical link
between increased SOD2 in the diaphragm fibers and a reduction in
MV-induced calpain activation is that oxidative stress promotes increased levels of cytosolic free calcium and therefore, increased calpain
activation [13]. It follows that an increase in diaphragmatic levels of
SOD2 likely protects against oxidative stress, calcium dysregulation,
and calpain activation in the diaphragm during prolonged MV.

protection against MV-induced contractile dysfunction, the increase in
SOD2 abundance functions in concert with other cytoprotective molecules in mediating exercise-induced protection against MV-induced
diaphragm contractile dysfunction.
In regard to other potential cytoprotective molecules, exercise
training also increases diaphragmatic levels of the chaperone protein
heat shock protein 72 (HSP72) [34]. This is potentially important because previous experiments have demonstrated that HSP72 overexpression alone prevents disuse muscle atrophy in locomotor skeletal
muscles [32]. Therefore, it is feasible that exercise-induced protection
against MV-induced diaphragm contractile dysfunction occurs via a
combination of exercise-induced increases in cytoprotective molecules.
Hence, additional research on this topic is required to determine if increases in SOD2 act in concert with increases in HSP72 to provide the
exercise-induced protection against MV-induced impairments in diaphragm contractile properties.
To investigate the mechanisms responsible for the exercise-induced
protection against MV-induced proteolysis and diaphragm atrophy
conferred by increased SOD2, we examined numerous biomarkers of
proteolysis in the diaphragm (calpain activity, ubiquitin ligases MuRF1
and Atrogin-1) and diaphragm fiber CSA. Based on our previous research in exercise-induced cardioprotection [11,14], we hypothesized
that exercise-induced increases in SOD2 in the diaphragm are required
to provide protection against MV-induced proteolysis and diaphragm
fiber atrophy.
Our results support the conclusion that increases in diaphragmatic
SOD2 are important for the prevention of MV-induced calpain activation and increased E3 ubiquitin ligase mRNA expression in the diaphragm. This is significant because previous experiments reveal that
pharmacological inhibition of calpain activation protects the diaphragm against MV-induced atrophy [21]. In the current study, we
demonstrate that exercise training prevents MV-induced calpain activation in the diaphragm and that this protection against calpain activation is abolished without an exercise-induced increase in diaphragmatic levels of SOD2. Additionally, prevention of the exercise-induced

4.4. Transgenic overexpression of SOD2 alone in the diaphragm provides
limited protection against VIDD
Although increases in diaphragmatic SOD2 contribute to exerciseinduced protection against VIDD, our findings indicate that overexpression of SOD2 does not provide the level of protection against
VIDD afforded by endurance exercise training. Indeed, overexpression
of SOD2 alone in the diaphragm provides only partial protection against
MV-induced diaphragm contractile dysfunction. This finding is consistent with the observation that prevention of the exercise-induced
increase of SOD2 in the diaphragm attenuates the exercise protection
against MV-induced diaphragm contractile dysfunction. Although the
mechanisms responsible for this SOD2-mediated protection are not
clear, it is likely that increases in diaphragmatic SOD2 defend against
MV-induced oxidative modification of contractile proteins in diaphragm fibers and the resultant contractile dysfunction.
Moreover, our findings reveal that transgenic overexpression of
SOD2 alone does not prevent MV-induced diaphragm proteolysis and
atrophy. Indeed, microtubule-associated protein light chain 3 II (LC3 II)
is a marker of autophagosome content [18] and is markedly increased
in the diaphragm of animals exposed to MV; nonetheless, transgenic
overexpression of SOD2 did not prevent this MV-induced increase in
LC3 II. Further, muscle specific E3 ubiquitin ligases MuRF1 and
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Atrogin-1 expression was significantly increased in diaphragms of MV
animals and transgenic overexpression of SOD2 alone provided only
partial protection against MV-induced increases. Together, these results
indicate that while increases in diaphragmatic SOD2 contribute to
diaphragm protection against VIDD, additional exercise-induced
changes in diaphragm phenotype are required to achieve the full exercise-induced protection against MV-induced proteolysis in the diaphragm.
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5. Conclusions
These experiments reveal for the first time that the exercise-induced
increase in SOD2 is required to achieve the full benefit of exercise-induced protection against VIDD. Additionally, overexpression of SOD2
alone in the diaphragm prior to MV only provides partial protection
against VIDD. These findings reveal that although increased expression
of SOD2 plays a role in exercise-induced protection against VIDD, an
increase in diaphragmatic SOD2 likely works in concert with other
cytoprotective molecules to provide the full exercise-induced protection
against VIDD.
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